FDA approves lisocabtagene maraleucel for relapsed or refractory mantle cell lymphoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-lisocabtagene-maraleucel-relapsed-or-refractory-mantle-cell-lymphoma